- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sodium Glucose Co-transporter (SGLT2 inhibitor)
Total 36648 results
-
Mansoura UniversityActive, not recruitingLupus Nephritis | BMD | SGLT2 INHIBITORSEgypt
-
Groupe Hospitalier Paris Saint JosephCompletedProton Pump InhibitorFrance
-
Institut Mutualiste MontsourisRecruitingCancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse EventFrance
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
University Hospital, Basel, SwitzerlandCompletedBariatric Surgery | Postprandial Hypoglycemia | Late Dumping SyndromeSwitzerland
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompleted
-
Seoul National University Bundang HospitalRecruitingDiabetes Mellitus | Fat; Intolerance, PancreasKorea, Republic of
-
China National Center for Cardiovascular DiseasesRecruiting
-
University of California, San FranciscoNot yet recruitingCystinuriaUnited States
-
Sohag UniversityCompletedType2 Diabetes | SGLT2 Inhibitors, First Time Use | Fasting in RamadanEgypt
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusCzechia, Hungary, United States, Mexico, Germany, Austria, Israel, Puerto Rico, Spain
-
Brigham and Women's HospitalUnknown
-
Hannover Medical SchoolBoehringer IngelheimTerminated
-
Beth Israel Deaconess Medical CenterJanssen Scientific Affairs, LLCCompletedObesity | Overweight | Type 2 DiabetesUnited States
-
Institut Mutualiste MontsourisInstitut CurieRecruitingCancer | Immune Checkpoint Inhibitor | Cardiovascular BiomarkersFrance
-
Kiyuk ChangSeoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaboratorsRecruitingMyocardial Infarction | Diabetes Mellitus, Type 2Korea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
McGill UniversityCompleted
-
Hellenic Cooperative Oncology GroupCompletedAutoimmune Diseases | Immunotherapy | Checkpoint InhibitorGreece
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingAcute Kidney Injury | Cardiac Surgery | Sodium-Glucose Transporter 2 InhibitorNetherlands
-
Yonsei UniversityUnknownType 2 Diabetes Mellitus | DyslipidemiasKorea, Republic of
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
University Health Network, TorontoAstraZeneca; University of Toronto; Toronto General HospitalCompletedFocal Segmental GlomerulosclerosisCanada
-
Institut de cancérologie Strasbourg EuropeNot yet recruiting
-
University Health Network, TorontoSunnybrook Health Sciences Centre; MOUNT SINAI HOSPITALRecruitingCardiovascular Risk FactorCanada
-
SanofiCompleted
-
Xiang XieXinjiang Medical UniversityNot yet recruitingCancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
-
University of Turin, ItalyUnknownDiabetes Mellitus, Type 2 | Body Weight Changes | Arterial HypertensionItaly
-
American Thrombosis and Hemostasis NetworkGenentech, Inc.Active, not recruitingHemophilia A With Inhibitor | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
Catalyst BiosciencesCompletedHemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without InhibitorBulgaria, Russian Federation
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationCompleted
-
Nanfang Hospital, Southern Medical UniversityRecruitingImmune Checkpoint Inhibitor Associated PneumoniaChina
-
Damanhour UniversityMenoufia UniversityUnknownCardiomyopathies | Diabete Type 2 | Heart Failure With Reduced Ejection Fraction (HFrEF)
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AKorea, Republic of, United States, France, Germany, Italy, South Africa, Spain, Japan, United Kingdom, Poland, Taiwan, Australia, Costa Rica, New Zealand
-
Shanghai 10th People's HospitalRecruiting
-
Amsterdam UMC, location VUmcCompleted
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteRecruitingType2Diabetes | ASCVDUnited States
-
Shanghai 10th People's HospitalCompleted
-
Mario Negri Institute for Pharmacological ResearchFederico II University; IRCCS MultimedicaCompletedProton Pump Inhibitor | Primary CareItaly
-
PfizerCompletedCarcinoma, Renal Cell | Lymphoma, Mantle-CellSpain
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Medical University of WarsawMedical University of Graz; Medical University of Vienna; Poznan University of... and other collaboratorsRecruitingAcute Decompensated Heart FailurePoland
-
Merck Sharp & Dohme LLCTerminatedColorectal Cancer | Advanced Solid Tumors
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
Mayo ClinicRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Doris...RecruitingType2 Diabetes | Heart Failure With Preserved Ejection FractionUnited States
-
Radboud University Medical CenterCompletedProton Pump Inhibitor | Inappropriate Drug Use | Discontinuation | E-healthNetherlands